Ambulatory Infusion Centers Market
完整報告名稱與涵蓋範圍
Ambulatory Infusion Centers Market Size, Share & Trends Analysis Report By Therapy Area (Oncology), By Ownership Model (Independent Centers), By Age Group, By Region, And Segment Forecasts, 2026 - 2033
報告摘要
Ambulatory Infusion Centers Market Summary
The global ambulatory infusion centers market size was estimated at USD 40.9 billion in 2025 and is projected to grow from USD 43.7 billion in 2026 to USD 76.2 billion by 2033, growing at a CAGR of 8.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 36.8% in 2025. This growth is attributed to the increasing prevalence of chronic diseases, expanding use of specialty infusion therapies, and the shift toward cost-effective outpatient care. Moreover, favorable reimbursement policies, increasing investments in independent infusion centers, and growing patient preference for convenient, accessible, and personalized infusion services are further supporting market expansion.
The section below outlines the key factors driving the growth of the ambulatory infusion centers market, highlighting the rising prevalence of chronic diseases requiring long-term infusion therapies and the growing shift from hospital-based care to cost-effective outpatient settings. It also examines the increasing adoption of specialty biologics and injectable therapies, favorable reimbursement policies, expanding investments in independent infusion centers, and rising patient preference for convenient, accessible, and personalized infusion services.
Global Ambulatory Infusion Centers Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on industry trends in each of the segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the ambulatory infusion centers market report on the basis of therapy area, ownership model, age group and region:
• Therapy Area Outlook (Revenue, USD Million, 2021 - 2033)
• Oncology
• Autoimmune & Inflammatory Disorders
• Neurology
• Infectious Diseases
• Hematology
• Immunodeficiency Disorders
• Endocrine & Metabolic Disorders
• Rare Diseases
• Others
• Ownership Model Outlook (Revenue, USD Million, 2021 - 2033)
• Independent Centers
• Hospital-Owned Centers
• Physician-Owned Centers
• Specialty Pharmacy-Owned Centers
• Age Group Outlook (Revenue, USD Million, 2021 - 2033)
• Pediatric
• Adult
• Geriatric
• Regional Outlook (Revenue in USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Sweden
o Denmark
o Norway
• Asia Pacific
o China
o India
o Japan
o Australia
o South Korea
o New Zealand
• Latin America
o Brazil
o Argentina
• MEA
o South Africa
o Saudi Arabia
o Kuwait
o UAE
授權報價
| Single User License | $5,950 USD |
| Enterprise License | $6,950 USD |
| Corporate User License | $8,950 USD |
目錄 Table of Contents
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Therapy Area
1.1.2. Ownership Model
1.1.3. Age Group
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Therapy area outlook
2.2.2. Ownership model outlook
2.2.3. Age group outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Ambulatory Infusion Centers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising adoption of biologic and specialty drugs
3.2.1.2. Growing shift from hospital-based infusion to cost-effective ambulatory care
3.2.2. Market restraint analysis
3.2.2.1. Shortage of skilled infusion nurses and healthcare professionals
3.2.3. Market opportunity analysis
3.2.4. Market challenge analysis
3.3. Ambulatory Infusion Centers Market Analysis Tools
3.3.1. Porter’s five forces analysis
3.3.2. PESTLE analysis
Chapter 4. Ambulatory Infusion Centers Market: Therapy Area Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Therapy Area Market Share, 2025 & 2033
4.3. Segment Dashboard
4.4. Global Ambulatory Infusion Centers Market by Therapy Area Outlook
4.4.1. Oncology
4.4.1.1. Oncology Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.2. Autoimmune & Inflammatory Disorders
4.4.2.1. Autoimmune & Inflammatory Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.3. Neurology
4.4.3.1. Neurology Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.4. Infectious Diseases
4.4.4.1. Infectious Diseases Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.5. Hematology
4.4.5.1. Hematology Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.6. Immunodeficiency Disorders
4.4.6.1. Immunodeficiency Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.7. Endocrine & Metabolic Disorders
4.4.7.1. Endocrine & Metabolic Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.8. Rare Diseases
4.4.8.1. Rare Diseases Market estimates and forecast, 2021 to 2033 (USD Million)
4.4.9. Others
4.4.9.1. Others Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 5. Ambulatory Infusion Centers Market: Ownership Model Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Ownership Model Market Share, 2025 & 2033
5.3. Segment Dashboard
5.4. Global Ambulatory Infusion Centers Market by Ownership Model Outlook
5.4.1. Independent Centers
5.4.1.1. Independent Centers Market estimates and forecast, 2021 to 2033 (USD Million)
5.4.2. Hospital-Owned Centers
5.4.2.1. Hospital-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
5.4.3. Physician-Owned Centers
5.4.3.1. Physician-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
5.4.4. Specialty Pharmacy-Owned Centers
5.4.4.1. Specialty Pharmacy-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 6. Ambulatory Infusion Centers Market: Age Group Estimates & Trend Analysis
6.1. Definition and Scope
6.2. Age Group Market Share, 2025 & 2033
6.3. Segment Dashboard
6.4. Global Ambulatory Infusion Centers Market by Age Group Outlook
6.4.1. Pediatric
6.4.1.1. Pediatric Market estimates and forecast, 2021 to 2033 (USD Million)
6.4.2. Adult
6.4.2.1. Adult Market estimates and forecast, 2021 to 2033 (USD Million)
6.4.3. Geriatric
6.4.3.1. Geriatric Market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 7. Ambulatory Infusion Centers Market: Regional Estimates & Trend Analysis, By Therapy Area, By Ownership Model, By Age Group
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. New Zealand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market position analysis, 2025
8.3.1. Option Care Health, Inc.
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Service benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Coram CVS Specialty Infusion Services
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Service benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Amerita, Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Service benchmarking
8.3.3.4. Strategic initiatives
8.3.4. KabaFusion
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Service benchmarking
8.3.4.4. Strategic initiatives
8.3.5. BioMatrix Specialty Pharmacy
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Service benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Paragon Healthcare, Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Service benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Healix, Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Service benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Vivo Infusion
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Service benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Pure Infusion
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Service benchmarking
8.3.9.4. Strategic initiatives
8.3.10. AIS Healthcare
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Service benchmarking
8.3.10.4. Strategic initiatives
圖表清單 List of Tables & Figures
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 4 North America ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 5 North America ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 6 U.S. ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 7 U.S. ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 8 Canada ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 9 Canada ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 10 Canada ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 11 Mexico ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 12 Mexico ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 13 Mexico ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 14 Europe ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 15 Europe ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 16 Europe ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 17 UK ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 18 UK ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 19 UK ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 20 Germany ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 21 Germany ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 22 Germany ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 23 France ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 24 France ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 25 France ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 26 Italy ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 27 Italy ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 28 Italy ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 29 Spain ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 30 Spain ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 31 Spain ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 32 Sweden ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 33 Sweden ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 34 Sweden ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 35 Denmark ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 36 Denmark ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 37 Denmark ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 38 Norway ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 39 Norway ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 40 Norway ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 41 Asia Pacific ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 42 Asia Pacific ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 43 Asia Pacific ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 44 Japan ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 45 Japan ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 46 Japan ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 47 China ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 48 China ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 49 China ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 50 India ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 51 India ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 52 India ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 53 Australia ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 54 Australia ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 55 Australia ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 56 South Korea ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 57 South Korea ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 58 South Korea ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 59 Thailand ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 60 Thailand ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 61 Thailand ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 62 Latin America ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 63 Latin America ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 64 Latin America ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 65 Brazil ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 66 Brazil ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 67 Brazil ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 68 Argentina ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 69 Argentina ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 70 Argentina ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 71 MEA ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 72 MEA ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 73 MEA ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 74 South Africa ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 75 South Africa ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 76 South Africa ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 77 Saudi Arabia ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 78 Saudi Arabia ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 79 Saudi Arabia ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 80 UAE ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 81 UAE ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 82 UAE ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
Table 83 Kuwait ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
Table 84 Kuwait ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
Table 85 Kuwait ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Ambulatory infusion centers market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Supply-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Market segmentation
Fig. 10 Market segmentation
Fig. 11 Competitive landscape
Fig. 12 Parent market outlook
Fig. 13 Ambulatory infusion centers market dynamics
Fig. 14 Ambulatory infusion centers market: Porter’s five forces analysis
Fig. 15 Ambulatory infusion centers market: PESTLE analysis
Fig. 16 Ambulatory infusion centers market: Therapy area segment dashboard
Fig. 17 Ambulatory infusion centers market: Therapy area market share analysis, 2025 & 2033
Fig. 18 Oncology ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 19 Autoimmune & inflammatory disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 20 Neurology ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 21 Infectious diseases ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 22 Hematology ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 23 Immunodeficiency disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 24 Endocrine & metabolic disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 25 Rare diseases ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 26 Others ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 27 Ambulatory infusion centers market: Ownership model segment dashboard
Fig. 28 Ambulatory infusion centers market: Ownership model market share analysis, 2025 & 2033
Fig. 29 Independent centers, market, 2021 - 2033 (USD Million)
Fig. 30 Hospital-owned centers, market, 2021 - 2033 (USD Million)
Fig. 31 Physician-owned centers, market, 2021 - 2033 (USD Million)
Fig. 32 Specialty pharmacy-owned centers, market, 2021 - 2033 (USD Million)
Fig. 33 Ambulatory infusion centers market: Age group segment dashboard
Fig. 34 Ambulatory infusion centers market: Age group market share analysis, 2025 & 2033
Fig. 35 Pediatric market, 2021 - 2033 (USD Million)
Fig. 36 Adults market, 2021 - 2033 (USD Million)
Fig. 37 Geriatric market, 2021 - 2033 (USD Million)
Fig. 38 Ambulatory infusion centers market revenue, by region, 2025 & 2033, (USD Million)
Fig. 39 Regional marketplace key takeaways
Fig. 40 Regional marketplace key takeaways
Fig. 41 North America ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 U.S. ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Canada ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Mexico ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 48 Europe ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Germany ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 UK ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 France ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Italy ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Spain ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Sweden ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Norway ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Denmark ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 65 Asia Pacific ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Japan ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 China ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 India ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Australia ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 South Korea ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 New Zealand ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 78 Latin America ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Brazil ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Argentina ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 83 Middle East & Africa ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 South Africa ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Saudi Arabia ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 UAE ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Kuwait ambulatory infusion centers market, 2021 - 2033 (USD Million)
Fig. 92 Company/competition categorization
Fig. 93 Company market position analysis, 2025
Fig. 94 Strategy mapping
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們